10 completed, 1 recruiting. 6 Phase 4, 3 Phase 3, 1 Phase 2.
By phase and status
Follow ELLIPTA: new trials by email Literature Review of ELLIPTA trials Research Report on ELLIPTA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
A Study to Evaluate the Safety and Efficacy of Fluticasone Furoate (FF)/Umeclidinium(UMEC)/Vilanterol (VI) in Participants With Chronic Obstructive Pulmonary Disease (COPD)
FF/UMEC/VI, ELLIPTA - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 229 | 2023-06-06 | 2025-03-24 |
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
FF/UMEC/VI, ELLIPTA, FF/VI - Asthma | Phase 3 | Recruiting | 138 | 2023-04-24 | 2026-09-30 |
Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
FF/VI, FF/UMEC/VI, ELLIPTA - Asthma | Phase 3 | Completed | 359 | 2021-07-29 | 2025-08-11 |
A Comparison of Critical Errors, Overall Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA Versus BREEZHALER Dry Powder Inhalers (DPIs) in Adult Participants With Asthma
ELLIPTA, BREEZHALER - Asthma | Phase 4 | Completed | 114 | 2021-04-14 | 2023-05-15 |
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 732 | 2018-06-25 | 2020-10-28 |
A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 729 | 2018-06-25 | 2020-10-28 |
Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness
UMEC/VI, FLUT/SAL, CAT - Pulmonary Disease, Chronic Obstructive | | Completed | 789 | 2018-05-31 | 2020-08-05 |
A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute Exacerbation
GSK2269557, Placebo, DISKUS - Pulmonary Disease, Chronic Obstructive | Phase 2 | Completed | 44 | 2015-11-04 | 2021-09-05 |
To Study Device Attributes by Investigating Errors Made in Use, Ease of Use and Preference Among Different Inhalers in Subjects With Asthma
ELLIPTA, DISKUS/ACCUHALER, MDI - Asthma | Phase 4 | Completed | 162 | 2014-11-01 | 2015-11-23 |
Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices
ELLIPTA, DISKUS/ACCUHALER, MDI - Pulmonary Disease, Chronic Obstructive | Phase 4 | Completed | 569 | 2014-08-28 | 2017-05-23 |
DISKUS vs. ELLIPTA Device Preference Study in Chronic Obstructive Pulmonary Disease (COPD)
ELLIPTA, DISKUS - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | 287 | 2013-05-01 | 2014-03-04 |
Conditions studied
Pulmonary Disease, Chronic Obstructive (7) · Asthma (4)
Sponsors
GlaxoSmithKline (11)
Countries
United States (5) · Netherlands (4) · Czechia (2) · Germany (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Canada (1) · Chile (1) · China (1) · Denmark (1) · India (1) · Israel (1) · Mexico (1) · New Zealand (1)
Results publications
PMID 27883002, PMID 26516724, PMID 36368290
NIH funding
2017 (2), 2015 (1)